Back to Main Entrance

Scientific Program

October 1, 2021

Nurses Program – starting at 11:00 CEST

Supported by an unrestricted grant by Ferring Pharmaceuticals

Welcome: Milton Leong, Hong Kong and Zeev Shoham, Israel
Session 1: Fertility Nursing past and present
Judith Smith, UK
Session 2: The role of the Fertility Nurse in the UK, education, and development now
Katie Best, UK
Session 3: The neuroendocrinology control of the reproductive system
Dominique de Ziegler, France
Session 4: The protocols for ovarian stimulation
Ariel Weissman, Israel
Session 5: The experience of the nurse from OR
Preparing for OPU, Set-up Tips for Success
Sophie Hall – Registered Nurse, Royal Women’s Hospital, Sydney, Australia
An Egg’s Journey, from OPU to Laboratory
Sarah Dalati – Senior Embryologist, Fertility & Research Centre, Sydney, Australia
Session 6: The different procedures that take place in the IVF Lab
Jessica Bailey, USA

Main Program – starting at 14:00 CEST
(Paris – 14:00, Cairo 15:00, Hong Kong – 20:00, San Diego – 05:00, New York – 08:00, Buenos Aires – 09:00)

Welcome
Milton Leong,  Hong Kong, Botros Ritz, USA, Zeev Shoham, Israel
Special lecture
The Corona 19 virus and the reproductive organs. Summarizing almost two years of unknown consequences and different guidelines. What information are we still missing?
Virgilio Novero, Philippines
Session 1: Embryo formation and development
How the concept of eugenics has evolved from idea to reality
David Albertini, USA
Imaging how cells change their fate, shape and position to form the preimplantation embryo
Nicolas Plachta, USA
Reproducing and the End of Life: Genesis through Deuteronomy, α to Ω
Gerald Schatten, USA
Special Lecture
For receiving special honor by Her Majesty, the Queen of the United Kingdom
Commanders of the Order of the British Empire (CBE) for Services to Female Reproductive Biology
A personal Journey towards developing In Vitro Follicle Growth Systems (IVG): It takes a community
Evelyn Telfer, UK
Session 2: Innovation In the field of Reproductive Medicine
Genetic innovations from the standpoint of Precision Medicine in Reproductive Medicine
Carlos Simon, Spain
Artificial intelligence technologies in ART: Future role
Charles Bormann, USA
The future is bright, the future is frozen
Charles Kingsland, UK
Evidence based ET timing
Tsafrir Kolatt, Israel
Session 3: Improving efficacy and efficiency in your clinic
Supported by Vitrolife
Optimization of oocyte collection: efficacy and safety
William Ledger, Australia
Workflow efficiency related to iDAScore
Marcos Meseguer, Spain
Peculiarities of work with EmbryoGlue for successful results
Olga Morozova, Russia

October 2, 2021

Nurses Program – starting at 11:00 CEST

Supported by an unrestricted grant by Ferring Pharmaceuticals

Session 7: The role of monitoring the stimulation treatment
Seang Lin Tan, Canada
Session 8: The journey of the sperm
Sherman Silber, USA
Session 9: Genetics for nurses
Discuss basic genetic concepts, recognize common genetic tests in the ART setting, evaluate common genetics issues that may arise in the ART setting and when referrals are indicated
Yaron Yuval, Israel
Session 10: Making eggs and sperm from a person’s skin cells
Sherman Silber, USA

Main Program – starting at 14:00 CEST
(Paris – 14:00, Cairo 15:00, Hong Kong – 20:00, San Diego – 05:00, New York – 08:00, Buenos Aires – 09:00)

GE Symposium
More Than Just Follicles – A Practical Guide to Expanding Ultrasound Use in Your Practice
Melissa Bunk, USA
Session 4: Treating the unfavorable prognosis patient in IVF
Organized by: The Center for Human Reproduction (CHR), New York, N.Y
Introduction by Norbert Gleicher, USA
20 years of IVF stagnation, a main reason being automatic rejection of women above age 42-43 for autologous IVF
Norbert Gleicher, USA
Androgen-induced epigenetic modulations in the ovary
Aritro Sen, USA
Why IVF cycles in poor prognosis patients must be highly individualized
David H. Barad, USA
Why poor prognosis patient should be the last candidates for PGT-A
Pasquale Patrizio, USA
Special Lecture
Customer Experience: Utilizing a highly accurate, efficient, and reliable assay for the detection of aneuploidy in pre-implantation embryo biopsy samples
Adam Goodman, USA
Session 5
Introduction by Botros Rizk, USA
The chamber of secrets: Indicator for embryo transfer success
Charles Kingsland, UK
Plasticity of the human embryo: lessons learned from time-lapse imaging in the IVF lab and its synergies with PGT
Alison Campbell, UK
Immortality through ART: How ART combined with space research will change the future of humanity
Ertug Kovanci, USA
Session 6: Advanced maternal age and complications of pregnancy
Chair: Alon Ben Arie, Israel
Challenges of being pregnant above the age of 50
Edi Vaisbuch, Israel
Progesterone in women with a mid-trimester short cervix reduces spontaneous preterm birth and neonatal morbidity: Changing the practice of obstetrics
Roberto Romero, USA
Session 7: Endometriosis and infertility
The use of oral GnRH antagonists
Ziv Tsafrir, Israel
The most promising data of using progetogens among women with endometriosis and infertility
Svetlana Dubrovina, Russia
Endometriosis: Surgical treatment for reproduction
Olivier Donnez, Belgium
Session 8: Special lecture
Navigating Patients’ Hopes and Fertility Reality: Psychological Mechanisms to the Rescue
Talya Miron-Shatz, Israel

October 3, 2021

Nurses Program – starting at 11:00 CEST

Supported by an unrestricted grant by Ferring Pharmaceuticals

Session 11: Fertility preservation
Marie-Madeleine Dolmans, Belgium
Session 12: PCOS an update: History, definition, and treatment
Raoul Orvieto, Israel
Closing remarks: Milton Leong, Hong Kong and Zeev Shoham, Israel

Main Program – starting at 14:00 CEST
(Paris – 14:00, Cairo 15:00, Hong Kong – 20:00, San Diego – 05:00, New York – 08:00, Buenos Aires – 09:00)

Session 9: Why most add-ons hurt IVF outcomes
Organized by: The International Do No Harm Group in IVF (IDNHG-IVF)
Introduction by Norbert Gleicher, USA
Defining add-ons and how they should be introduced to IVF
Joyce Harper, UK
Extended culture to blastocyst, add-on or routine IVF practice?
Demian Glujovsky, Argentina
PGT-A, the most consequential add-on to IVF of them all
Raoul Orvieto, Israel
Embryo banking/freezing another unsupported fashion of the moment
Norbert Gleicher, USA
Session 10: The sperm
Introduction by Botros Ritz, USA, Zeev Shoham, Israel
Intracytoplasmic sperm injection versus conventional in-vitro fertilization in couples with infertility in whom the male partner has normal total sperm count and motility
Ben Mol, Australia
Management of azoospermia and ART
Medhat Amer, Egypt
Session 11: New perspective on the Luteal phase support
Introduction by Ariel Weissman, Israel
Should women receive luteal support following natural cycle frozen embryo transfer?
Yossi Mizrachi, Australia
Progesterone free luteal support in IVF
Shahar Kol, Israel
GnRh analog as a sole luteal support in ART treatments
Itai Bar-Hava, Israel
Session 12: New approach to IVF
A new approach makes Saline Infusion Sonography (SIS) simpler and more user friendly
Dominique de Ziegler, France
Ultrasonography, SIS and Hysteroscopy in uterine septum and anomalies
Botros Rizk, USA
Mini/IVF
Sherman Silber, USA
The application of progestin-primed ovarian stimulation (PPOS) in women with polycystic ovarian syndrome
Kuang Yanping, China
Session 13: Next generation ART
Organized by the Latin-American Association for Reproductive Medicine (ALMER)
Introduction by Ricardo Loret de Mola, USA & Marcelo Barrionuevo, USA
New biomarkers of embryo development
Gianpiero Palermo, USA
Future of PGT
Nathan Treff, USA
Artificial intelligence in ART
Cristina Hickman, UK
Session 14: How can we work with the social media: practical ideas for improving patient communications
Organized by Vanguard Communications, USA
Five ways to Optimize Patient Communications to Optimize Outcomes
Stephanie Wilson, USA and Selene Neuburg, USA
Fighting Fertility Myths & Misinformation on social media
Ron Harman King, USA
Closing remarks
Milton Leong, Hong Kong, Botros Ritz, USA, Zeev Shoham, Israel